Somatic pathogenic variants in the ED of POLE have been identified in 2–8% of colorectal cancer (CRC),11–14 7–15% of endometrial tumors,15–18 and more rarely in other tumor types.19–21 Somatic pathogenic variants affecting POLD1 ED are extremely rare. This evidence concerns the gene POLE and colorectal carcinoma.